IN-VIVO METABOLITES OF SPIRONOLACTONE AND POTASSIUM CANRENOATE: DETERMINATION OF POTENTIAL ANTI-ANDROGENIC ACTIVITY BY A MOUSE KIDNEY CYTOSOL RECEPTOR ASSAY-Reference-Cited by-同舟云学术

IN-VIVO METABOLITES OF SPIRONOLACTONE AND POTASSIUM CANRENOATE: DETERMINATION OF POTENTIAL ANTI-ANDROGENIC ACTIVITY BY A MOUSE KIDNEY CYTOSOL RECEPTOR ASSAY

Published:1985-10 Issue:4 Volume:23 Page:341-347
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

ARMANINI D.,KARBOWIAK ISABELLA,GOI ANNA,MANTERO F.,FUNDER J. W.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1985.tb01090.x/fullpdf

Reference18 articles.

1. Pharmacokinetics of spironolactone in man

2. Increased Plasma 11-Deoxycorticosterone During Spironolactone Medication

3. Antiandrogenic Effects of Spironolactone: Hormonal and Ultrastructural Studies in Dogs and Men

4. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.

5. A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment;Journal of Endocrinological Investigation;2021-01-16

2. Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy;Frontiers in Endocrinology;2019-08-23

3. A short review of primary aldosteronism in a question and answer fashion;Endocrine Regulations;2018-01-01

4. Spironolactone in the treatment of polycystic ovary syndrome;Expert Opinion on Pharmacotherapy;2016-07-29

5. Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI;Journal of Endocrinological Investigation;2016-04-12